BPC-157, KPV, and Thymosin Beta-4 have not completed Phase III trials, are not FDA-approved for IBD, and lack the extensive safety and efficacy data biologics possess
Week 1-2 Initial tissue healing response begins Week 2-4 Visible skin improvements may begin Week 4-8 Collagen synthesis and regeneration effects Week 8-12 Peak effects
Anyone with a personal or family history of certain thyroid cancers, pancreatitis, or serious gastrointestinal disease sits outside the comfortable-experimentation zone these compounds occupy, since those conditions appeared in trial exclusion criteria for good reason
NON-GMO & GLUTEN-FREE TRUSTED QUALITY: Non-GMO, gluten-free, soy-free with no added preservatives
Initial fatigue: Some users report tiredness during the first few days